¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pregnancy, multiple"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
¿µ¹® tubal pregnancy ÇÑ±Û ÀڱðüÀÓ½Å
¼³¸í   
  ³­°ü³»¿¡ ÀϾ ÀڱÿÜÀÓ½Å. ´ë°³ ÀÓ½ÅÀ» ³¡±îÁö Áö¼Ó½ÃŰÁö ¸øÇϰí À¯»êÇϰųª, È¤Àº º¹°­³»·Î ÅÍÁ® ¸ñ¼ûÀÌ À§Å·ӰԠµÇ±âµµ ÇÑ´Ù. ºü¸¥ Áø´ÜÀ¸·Î ÀϾ ÇÕº´ÁõÀ» ¿¹¹æÇؾߠÇÑ´Ù.
¿µ¹® ectopic pregnancy ÇÑ±Û ÀÚ±Ã¿Ü ÀÓ½Å
¼³¸í   
  »êºÎÀΰú ¿µ¿ª¿¡¼­ °¡Àå ºó¹øÇÑ ÀÀ±Þ º´À¸·Î, ±× ¹ß»ý ºóµµ´Â ¸Å³â Áõ°¡Çϴ Ãß¼¼ÀÌ´Ù. ÀڱÿܠÀÓ½ÅÀº ¼öÁ¤¶õÀÌ Á¤»óÀûÀΠÀ§Ä¡ÀΠÀڱøöÅëÀÇ ³»°­¿¡ Âø»óµÇÁö ¾Ê°í ´Ù¸¥ °÷, Áï ³­¼Ò¿¡¼­ ³ª¿Â ³­ÀÚ¸¦ ÀڱñîÁö ¿î¹ÝÇϴ Àڱðü, ³­ÀÚ¸¦ »ý»êÇϴ ³­¼Ò, ÀÚ±ÃÀ» ÁöÁöÇϴ ¿©·¯ Àδë, º¹°­, ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇϴ ÀڱðæºÎ µî¿¡ Âø»óµÇ´Â ÀÓ½ÅÀ» ¸»ÇÑ´Ù.
  
  Âø»óÇϴ ºÎÀ§¿¡ µû¶ó Àڱðü ÀÓ½Å, Àڱøñ°ü ÀÓ½Å, ³­¼Ò ÀÓ½Å, º¹¸·ÀÓ½Å, Àδ볻 ÀӽеîÀ¸·Î ³ª´µ¸ç, °¡Àå ÈçÇÑ ÀڱÿܠÀÓ½ÅÀº Àڱðü ÀÓ½ÅÀÌ´Ù. ÀڱÿܠÀÓ½ÅÀÌ Áõ°¡Çϴ ÀÌÀ¯·Î´Â ¿ì¼± ºÒ°áÇÑ ¼ºÀû Á¢ÃË¿¡ ÀÇÇØ ÀüÆÄµÇ´Â ±Þ¼º ³­°ü¿°ÀÇ Áõ°¡¸¦ »ý°¢ÇÒ ¼ö ÀÖ´Ù. ½ÇÁ¦ ±Þ¼º ³­°ü¿°À» ¾Î¾Ò´ø ¿©¼ºÀº ±× ´ÙÀ½ Àӽſ¡¼­ ÀڱÿܠÀÓ½ÅÀÌ µÉ È®·üÀÌ Á¤»óÀο¡ ºñÇÏ¿© 7¹è³ª ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ¶ÇÇÑ Àڱó» ÇÇÀÓÀåÄ¡¸¦ »ç¿ëÇϴ ¿©¼º¿¡¼­µµ Á¤»óÀκ¸´Ù ³ôÀº À²ÀÇ ÀڱÿܠÀÓ½ÅÀÌ º¸°íµÇ¾ú´Ù.
  
  ÀڱÿܠÀÓ½ÅÀÌ µÇ¸é ¹Ýµå½Ã ´Ù¾çÇÑ ÇüÅÂÀÇ ÇϺ¹ºÎ µ¿ÅëÀ» ³ªÅ¸³½´Ù. ´ëºÎºÐ ÃÖÁ¾ ¿ù°æÀÏÀ» ±âÁØÀ¸·Î 4ÁÖÂë ÈĺÎÅÍ ºÎÁ¤±â ÁúÃâÇ÷À» º¸ÀδÙ. ¶Ç °ú¹Ý¼öÀǠȯÀÚ¿¡¼­ À¯¹æÅëÀ̳ª ¸Ö¹Ì µîÀÌ ³ªÅ¸³ª±âµµ Çϳª, Ã¼¿Â »ó½ÂÀº µå¹°´Ù. ±×·¯³ª ºü¸¥¸ÆÀº ÈçÈ÷ º¸À̴ Áõ»óÀÌ´Ù. ÀڱÿܠÀÓ½ÅÀÇ ¹®Á¦Á¡Àº Á¡Á¡ ÀÚ¶õ Å¾ƷΠÀÎÇØ¼­ ÀڱÿܠÀÓ½ÅÀÌ µÈ ºÎÀ§(ƯÈ÷ Àڱðü)°¡ ±×°ÍÀÇ Å©±â¸¦ °ßµðÁö ¸øÇؼ­ ÆÄ¿­µÇ´Â °ÍÀÌ´Ù. ±×·¸°Ô µÇ¸é ¸¹Àº ¾çÀÇ Çǰ¡ ÇѲ¨¹ø¿¡ ÃâÇ÷ÀÌ µÇ¾î »ý¸íÀ» ÀÒÀ» ¼öµµ ÀÖ´Ù. ´ëºÎºÐÀÇ ÀڱÿܠÀÓ½ÅÀº ÇöÀçÀÇ ¹ß´ÞµÈ Áø´Ü¹æ¹ýÀ¸·Î ºü¸£°í Á¤È®ÇϰԠÁø´ÜÇÒ ¼ö ÀÖ´Ù. Áï Á÷Àå°ú ÀڱûçÀÌ¿¡ Á¸ÀçÇϴ º¹°­ÀÇ ÀϺκÐÀΠ¸·ÈùÁÖ¸Ó´Ï(º¹°­ Áß¿¡¼­ °¡Àå ³·Àº ºÎºÐ¿¡ Á¸ÀçÇÏ¿© º¹°­³»ÀÇ ÃâÇ÷À̳ª ±âŸÀÇ ¾×ü´Â À̺κп¡ ¸ðÀδÙ)õÀÚ¼ú·Î 0.5mmÀÌ»óÀÇ ºñÀÀÇ÷¼º Ç÷¾×ÀÇ ÈíÀÔÀÌ µÉ °æ¿ì¿¡ ÀڱÿܠÀÓ½ÅÀÇ ÆÄ¿­·Î ÀÎÇÑ ÃâÇ÷ÀÓÀ» ¾Ë ¼ö°¡ ÀÖ°í, ÃÊÀ½ÆÄ ¿µ»ó¹ý¿¡ ÀÇÇÑ Áø´Ü, ÃÖ±ÙÀÇ ¸é¿ª È­ÇÐÀû È£¸£¸ó ÃøÁ¤¹ý°ú º¹°­°æ °Ë»ç¹ý, ¶ÇÇÑ Àڱ󻸷 Á¶Á÷°Ë»ç µîÀ¸·Î½á Áø´ÜÇÒ ¼ö ÀÖ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hydatid pregnancy
    Æ÷»ó±âÅÂÀÓ½Å
  • imaginary pregnancy
    »ó»óÀÓ½Å
  • immunologic pregnancy test
    ¸é¿ªÀӽŹÝÀÀ°Ë»ç
  • interstitial pregnancy
    »çÀÌÁúÀÓ½Å, Àڱú®ÀڱðüÀÓ½Å
  • molar pregnancy
    ±âÅÂÀÓ½Å
  • mural pregnancy
    »çÀÌÁúÀÓ½Å, Àڱú®ÀڱðüÀÓ½Å
  • membranous pregnancy
    ¸·ÀÓ½Å, Àڱú®¸·ÀÓ½Å
  • mesenteric pregnancy
    âÀÚ°£¸·ÀÓ½Å, Àå°£¸·ÀÓ½Å
  • normal singleton pregnancy
    Á¤»ó¿Üµ¿ÀÓ½Å
  • ovarian pregnancy
    ³­¼ÒÀÓ½Å
  • plural pregnancy
    ´ÙÅÂÀÓ½Å, ¹µÀÓ½Å
  • pregnancy
    ÀÓ½Å
  • pregnancy gingivitis
    ÀÓ½ÅÀÕ¸ö¿°, ÀÓ½ÅÄ¡Àº¿°
  • pregnancy induced retinopathy
    ÀÓ½ÅÀ¯¹ß¸Á¸·º´(Áõ)
  • pregnancy luteoma
    ÀÓ½ÅȲ(»ö)üÁ¾
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • prolonged pregnancy
    Áö¿¬ÀÓ½Å
  • term pregnancy
    ¸¸±âÀÓ½Å
  • tubal pregnancy
    ÀڱðüÀÓ½Å
  • twin pregnancy
    ½ÖµÕÀÌÀÓ½Å
  • pregnancy rate
    Àӽŷü
  • pregnancy test
    ÀӽŰ˻ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hydatid pregnancy
    Æ÷»ó±âÅÂÀÓ½Å
  • hysteric pregnancy
    È÷½ºÅ׸®ÀÓ½Å
  • imaginary pregnancy
    »ó»óÀÓ½Å
  • interstitial pregnancy
    Àڱú®ÀڱðüÀÓ½Å, »çÀÌÁúÀÓ½Å
  • pregnancy luteoma
    ÀÓ½ÅȲüÁ¾
  • membranous pregnancy
    ¸·ÀÓ½Å
  • mesenteric pregnancy
    âÀÚ°£¸·ÀÓ½Å
  • mural pregnancy
    (¢¡interstitial pregnancy) Àڱú®ÀڱðüÀÓ½Å, »çÀÌÁúÀÓ½Å
  • ovarian pregnancy
    ³­¼ÒÀÓ½Å
  • pregnancy
    ÀÓ½Å
  • phantom pregnancy
    ȯ»óÀÓ½Å
  • plural pregnancy
    ´ÙÅÂÀÓ½Å
  • pregnancy rate
    ÀÓ½ÅÀ²
  • pregnancy test
    ÀӽŰ˻ç
  • pregnancy induced retinopathy
    ÀÓ½ÅÀ¯¹ß¸Á¸·º´Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypertrichosis gravitatis =Halban s pregnancy sign ³ª
    ÀÓºÎ(ìôÜþ)´Ù¸ð(Áõ).
  • hysteric pregnancy
    È÷½ºÅ׸®¼º ÀÓ½Å(¡­ìôãã) »ó»óÀÓ½Å(ßÌßÀìôãã) .
  • hysteric pregnancy
    È÷½ºÅ׸®¼º ÀÓ½Å(¡­ìôãã),»ó»óÀÓ½Å(ßÌßÀìôãã)
  • imaginary pregnancy
    »ó»óÀÓ½Å.
  • imaginary pregnancy
    »ó»óÀÓ½Å
  • plural pregnancy
    ´ÙÅÂÀÓ½Å(Òý÷Ãìôãã).
  • postterm pregnancy
    °ú±âÀÓ½Å, ¸¸±âÈÄÀÓ½Å
  • pregnancy
    ÀÓ½Å
  • pregnancy
    ÀÓ½Å(ìõãã)
  • pregnancy [gravidity]
    ÀÓ½Å
  • pregnancy luteoma
    ÀÓ½ÅȲüÁ¾(ìõããüÜô÷ðþ)
  • pregnancy rate
    ÀÓ½ÅÀ²(ìôããëÒ).
  • pregnancy test
    ÀӽŰ˻ç.
  • pregnancy tumor
    ÀÓ½ÅÁ¾¾ç(ìõããðþåË)
  • pregnancy ³ª praegnatio
    ÀÓ½Å(ìôãã).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ectopic pregnancy
    µý°÷ÀÓ½Å
  • ectopic pregnancy
    ÀÚ±Ã¿Ü ÀÓ½Å(í­Ïàèâ ìõãã)
  • ectopic pregnancy =e. fetation
    ÀڱÿÜÀÓ½Å, À̼Ҽº ÀÓ½Å.
  • exochorial pregnancy
    À¶¸ð¸·ÀÓ½Å(ëÖپد ìôãã).
  • extrauterine pregnancy
    ÀڱÿÜÀÓ½Å.
  • extrauterine pregnancy
    ÀڱùÛÀÓ½Å
  • fallopian pregnancy
    ³­°üÀÓ½Å(հηìôãã).
  • false pregnancy
    °¡¼ºÀÓ½Å.
  • gemellary pregnancy
    ½ÖÅÂÀÓ½Å.
  • graviditas =pregnancy<³ª>
    ÀÓ½Å.
  • heterotopic pregnancy
    ÀڱÿÜÀÓ½Å, À̼Ҽº(ì¶á¶àõ) ÀÓ½Å.
  • hydatid pregnancy
    ±âÅÂÀÓ½Å(ѱ÷Ãìôãã).
  • hypertrichosis gravitatis =Halban s pregnancy sign ³ª
    ÀÓºÎ(ìôÜþ)´Ù¸ð(Áõ).
  • hysteric pregnancy
    È÷½ºÅ׸®¼º ÀÓ½Å(¡­ìôãã),»ó»óÀÓ½Å(ßÌßÀìôãã)
  • hysteric pregnancy
    È÷½ºÅ׸®¼º ÀÓ½Å(¡­ìôãã) »ó»óÀÓ½Å(ßÌßÀìôãã) .
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • multiple exostoses
    ´Ù¹ß¼º¿Ü°ñÁõ
  • multiple fibroma
    ´Ù¹ß¼º¼¶À¯Á¾
  • multiple lymphomatous polyposis
    ´Ù¹ß¼º¸²ÇÁÁ¾¼º¿ëÁ¾Áõ
  • multiple myeloma
    ´Ù¹ß¼º°ñ¼öÁ¾
  • multiple overlapping thin slab acquisition [=MOTSA]
    ´ÙÁßÁߺ¹¼¼ÆíÆÇȹµæ
  • multiple polyp
    ´Ù¹ß¼ºÆú¸³
  • multiple sclerosis
    ´Ù¹ß¼º°æÈ­Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
grav. gravida; pregnancy; ÀÓ½Å
GTN   - Stages of GTN(FIGO, WHO)
    1. Stage O; Molar Pregnancy(H-Mole...
IDA   1) Imino-Diacetic Acid
  2) Iron Deficiency Anemia
   &nb...
PAPP Pregnancy Associated Plasma Protein
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IUP Intra Uterine Pregnancy
ICP Intra-hepatic cholestasis of pregnancy
MFPR Multifetal pregnancy reduction
NVP Nausea and vomiting of pregnancy
PAPP-A Pregnancy Associated Plasma Protein A
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • multiple anchorage
    º¹ÇÕ °íÁ¤
    1Çü½Ä ÀÌ»óÀÇ ÈûÀ» °¡ÇÏ´Â ÀåÄ¡¸¦ »ç¿ëÇÏ´Â °íÁ¤.
  • multiple angioma
    ´Ù¹ß¼º ¸Æ°üÁ¾
  • multiple biologically active peptide fragment
    ´Ù¹ß¼º »ý¹°ÇÐÀû Ȱ¼º ÆéŸÀÌµå ºÐÀý
  • multiple cavernous hemangioma
    ´Ù¹ß¼º ÇØ¸é Ç÷°üÁ¾
  • multiple condylome
    ´Ù¹ß¼º ½À¿ì
  • multiple cranial nerve palsy
    ´Ù¹ß¼º ³ú ½Å°æ ¸¶ºñ
  • multiple diagnosis
    º¹¼ö Áø´Ü
  • multiple drug misuse
    ¿©·¯ ¾à¹°ÀÇ ¿À¿ë
  • multiple drug resistance gene
    º¹ÇÕ ¾àÁ¦ ³»¼º À¯ÀüÀÚ
  • multiple endocrine neoplasia
    ´Ù¹ß¼º ³»ºÐºñ Á¾¾ç
  • multiple epiphyseal dysplasia
    ´Ù¹ß¼º °ñ´Ü ÀÌÇü¼ºÁõ
  • multiple epulides fissurata
    ´Ù¹ß¼º ¿­¼º Ä¡À°Á¾
  • multiple excitaiton
    ´ÙÁß ¿©±â
  • multiple factor
    ´Ù¹ß¼º ÀÎÀÚ
  • multiple fracture
    ´Ù¹ß¼º °ñÀý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
multiple drug resistant tuberculosis A strain of TB that does not respond to two or more standard anti-TB drugs. MDR-TB usually occurs when treatment is interrupted thus allowing mutations in the organism to occur that confer drug resistance.
(09 Oct 1997)
multiple ego states Various psychological organizational state's reflecting different personas or life experiences.
(05 Mar 2000)
multiple embolism Embolism caused by the arrest of a number of small emboli.
(05 Mar 2000)
multiple endocrine adenomatosis The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance.
Synonym: multiple endocrine adenomatosis.
(05 Mar 2000)
multiple endocrine deficiency syndrome <syndrome> Acquired deficiency of the function of several endocrine glands, usually on an auto-immune basis.
Synonym: multiple glandular deficiency syndrome.
(05 Mar 2000)
multiple endocrine neoplasia (type I) This is a hereditary disorder in which two or more of the following glands: parathyroid, pancreas, pituitary, adrenals or thyroid develop hyperplasia or a tumour.
(type II) This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
Origin: Gr. Plassein = to form
(27 Sep 1997)
multiple endocrine neoplasia 1 <radiology> Multiple endrocrine neoplasia syndrome three P's.
Pituitary adenoma, 65% can develop Cushing's, acromegaly, prolactinoma, parathyroid hyperplasia / adenoma, 88% can develop hyper-PTH
pancreatic isleT-cell tumour, gastrinoma (Z-E) most common, 50% of Z-E can develop MEN-1, inconstant features: bronchial/intestinal carcinoid, thyroid adenoma, adrenal cortical tumour, lipoma, thymoma tissue expression
Primary hyperparathyroidism (90%), Gastrinoma (30%), Prolactinoma (15%), Other (10%).
Synonym: Wermer syndrome
(12 Dec 1998)
multiple endocrine neoplasia 2 <radiology> Multiple endocrine neoplasia syndrome, medullary thyroid carcinoma, usually multifocal; metastasis to local nodes, lung, liver, usually calcify in liver, pheochromocytoma, almost always bilateral, parathyroid hyperplasia, may be secondary to calcitonin secreted by medullary thyroid carcinoma inconstant feature: adrenal cortical hyperplasia
Synonym: Sipple syndrome
(12 Dec 1998)
multiple endocrine neoplasia 3 <radiology> Multiple endocrine neoplasia syndrome (type 2B, type 3), medullary thyroid carcinoma, pheochromocytoma, marfanoid habitus (Cf: Marfan syndrome), mucosal neuromas, neurofibromas, ganglioneuromatosis coli More info: MEN syndrome 2B
Synonym: Schimke, marfanoid syndrome
(12 Dec 1998)
multiple endocrine neoplasia type 1 A rare syndrome characterised by hyperplasia and/or neoplasms of the pituitary, parathyroid glands, and pancreatic islets. Hyperparathyroidism occurs in 90% of the cases and is usually the first manifestation of the syndrome. The most frequent pancreatic manifestation is gastrinoma typically leading to zollinger-ellison syndrome. The appearance of this condition has been limited to the loss of allelic heterozygosity at the 11q13 locus on the long arm of chromosome 11. Patients overall exhibit long survival times. Chemotherapy is rare and surgical management is generally dependent on the genetic expression in individual patients.
(12 Dec 1998)
multiple endocrine neoplasia type 2 <syndrome> This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
(27 Sep 1997)
multiple endocrine neoplasia type 2a A type of multiple endocrine neoplasia characterised by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands.
(12 Dec 1998)
multiple endocrine neoplasia type 2b A type of multiple endocrine neoplasia occurring as an isolated congenital presentation or as a distinct autosomal dominant disease. It is characterised by the 100% incidence of medullary thyroid carcinoma and frequent pheochromocytomas; patients seldom exhibit hyperparathyroidism. It is distinguished from men 2a by its characteristic physical appearance resulting from numerous neural defects including mucosal neuromas of the eyelids, lips, and tongue. The neural abnormalities also include widespread neurogangliomatosis of the gastrointestinal tract leading to abnormal gut motility. Treatment usually requires total thyroidectomy following evaluation for the presence of pheochromocytomas.
(12 Dec 1998)
multiple epiphysial dysplasia A dominantly inherited abnormality of epiphyses characterised by difficulty in walking, pain and stiffness of joints, stubby fingers, and often dwarfism of short-limb type; on X-ray examination, the epiphyses are mottled and irregular; ossification centres are late in appearance and may be multiple, but the vertebrae are normal. There is also an autosomal recessive form .
Synonym: dysplasia epiphysialis multiplex.
(05 Mar 2000)
multiple exostosis A disturbance of enchondral bone growth in which multiple, generally benign osteochondromas of long bones appear during childhood, commonly with shortening of the radius and fibula; the ill-effects are usually mechanical but malignant change is rare; autosomal dominant inheritance.
Synonym: diaphysial aclasis, hereditary deforming chondrodystrophy, multiple exostosis, osteochondromatosis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á